SCHEMBL13621012

SCHEMBL13621012

c1ccc2oc(-c3ccc(-c4c5ccccc5c(-c5cccc6ncncc56)c5ccccc45)cc3)nc2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 9/20 0.46
ALDH1A1 P00352 8/20 0.46
HPGD P15428 7/20 0.46
KDM4E B2RXH2 6/20 0.46
SMN1; SMN2 Q16637 6/20 0.46
HSD17B10 Q99714 4/20 0.46
TP53 P04637 3/20 0.46
RAB9A P51151 8/20 0.46
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
ATM Q13315 1/20 0.46
MAPT P10636 4/20 0.43
USP2 O75604 2/20 0.43
HCRTR1 O43613 1/20 0.43
TSHR P16473 1/20 0.43
MAPK1 P28482 1/20 0.43
CASP3 P42574 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
SENP8 Q96LD8 1/20 0.43
SENP7 Q9BQF6 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13621006 0.84 NPC1 (0.51) NPC1ALDH1A1HPGDKDM4ESMN1; SMN2
SCHEMBL4359314 0.84 NPC1 (0.54) NPC1ALDH1A1HPGDKDM4ESMN1; SMN2
SCHEMBL13621001 0.84 ALDH1A1 (0.50) NPC1ALDH1A1HPGDKDM4ESMN1; SMN2
SCHEMBL13134554 0.83 ATR (0.45) NPC1ALDH1A1HPGDKDM4ESMN1; SMN2
SCHEMBL13621014 0.82 ALDH1A1 (0.56) NPC1ALDH1A1HPGDKDM4ESMN1; SMN2
SCHEMBL13621000 0.82 NPC1 (0.56) NPC1ALDH1A1HPGDKDM4ESMN1; SMN2
SCHEMBL13620995 0.81 ALDH1A1 (0.50) NPC1ALDH1A1HPGDKDM4ESMN1; SMN2
SCHEMBL13621020 0.81 NPC1 (0.48) NPC1ALDH1A1HPGDKDM4ESMN1; SMN2
SCHEMBL27365149 0.81 NPC1 (0.67) NPC1ALDH1A1HPGDKDM4ESMN1; SMN2
SCHEMBL13621016 0.80 NPC1 (0.52) NPC1ALDH1A1HPGDKDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8859108-B2 Benzoxazole derivative, and light-emitting element, light-emitting device, and electronic device using the same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-10-14 US disclosed
US-8859108-B2 Benzoxazole derivative, and light-emitting element, light-emitting device, and electronic device using the same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-10-14 US disclosed
US-20090286985-A1 Benzoxazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using the Same SEMICONDUCTOR ENERGY LABARATORY CO., LTD. 2009-11-19 US disclosed
US-20090286985-A1 Benzoxazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using the Same SEMICONDUCTOR ENERGY LABARATORY CO., LTD. 2009-11-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090286985-A1 Benzoxazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using the Same CYP4X1, XDH, GABRA5 NPC1 3482/4885ALDH1A1 169/4885HPGD 700/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.